{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:29:25Z","timestamp":1792625365447,"version":"4.5.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Group 2 innate lymphoid cells (ILC2s) are critical for type 2 inflammation. In murine models of asthma, some ILC2s remain activated in the absence of epithelial cell\u2013derived cytokine signaling, implicating alternate stimulatory pathways. DR3 (death receptor 3), a member of the tumor necrosis factor receptor superfamily, is expressed on ILC2s. Genome-wide association studies report an association between DR3 ligand, TL1A (tumor necrosis factor\u2013like protein 1A), and chronic inflammatory conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We investigated the TL1A\/DR3 axis in airway ILC2 biology in eosinophilic asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Stable subjects with mild asthma were subject to allergen inhalation challenge, and DR3 expression on sputum cells was assessed. We investigated cytokine regulation of DR3 expression on ILC2s and steroid sensitivity. Airway TL1A was assessed in sputum from subjects with mild asthma and subjects with prednisone-dependent severe eosinophilic asthma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>There was a significant increase in sputum DR3+ ILC2s 24 hours after allergen challenge, and DR3 expression on ILC2s was upregulated by IL-2, IL-33, or TSLP in vitro. Stimulation with TL1A significantly increased IL-5 expression by ILC2s and was attenuated by dexamethasone, an effect that was negated in the presence of TSLP. Airway TL1A levels were increased 24 hours after allergen challenge in subjects with mild asthma but were significantly greater in those with severe eosinophilic asthma. The highest levels were detected in subjects with severe asthma with airway autoimmune responses. C1q+ immune complexes from the sputa of subjects with severe asthma with high autoantibody levels stimulated TL1A production by monocytes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The TL1A\/DR3 axis is a costimulator of ILC2s in asthma, particularly in the airways of patients with a predisposition to autoimmune responses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201909-1722oc","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T14:34:21Z","timestamp":1593095661000},"page":"1105-1114","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":64,"title":["The Role of the TL1A\/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma"],"prefix":"10.1093","volume":"202","author":[{"given":"Kentaro","family":"Machida","sequence":"first","affiliation":[{"name":"CardioRespiratory Research Group, Division of Respirology, Department of Medicine, and"},{"name":"Department of Pulmonary Medicine, Graduate School of Medical & Dental Sciences, Kagoshima University, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aw","sequence":"additional","affiliation":[{"name":"CardioRespiratory Research Group, Division of Respirology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany M. A.","family":"Salter","sequence":"additional","affiliation":[{"name":"CardioRespiratory Research Group, Division of Respirology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Ju","sequence":"additional","affiliation":[{"name":"CardioRespiratory Research Group, Division of Respirology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Firestone Institute for Respiratory Health, St. Joseph\u2019s Healthcare, McMaster University, Hamilton, Ontario, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail M.","family":"Gauvreau","sequence":"additional","affiliation":[{"name":"CardioRespiratory Research Group, Division of Respirology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"O\u2019Byrne","sequence":"additional","affiliation":[{"name":"CardioRespiratory Research Group, Division of Respirology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswaran","family":"Nair","sequence":"additional","affiliation":[{"name":"Firestone Institute for Respiratory Health, St. Joseph\u2019s Healthcare, McMaster University, Hamilton, Ontario, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0968-6304","authenticated-orcid":false,"given":"Roma","family":"Sehmi","sequence":"additional","affiliation":[{"name":"CardioRespiratory Research Group, Division of Respirology, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"2026030321495917200_bib1","article-title":"Global strategy for asthma management and prevention, Global Initiative for Asthma (GINA)","author":"GINA","year":"2018 [2018  1]"},{"key":"2026030321495917200_bib2","doi-asserted-by":"crossref","first-page":"15025","DOI":"10.1038\/nrdp.2015.25","article-title":"Asthma","volume":"1","author":"Holgate","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2026030321495917200_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2013.05.007","article-title":"What is an \u201ceosinophilic phenotype\u201d of asthma?","volume":"132","author":"Nair","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321495917200_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJM199010113231505","article-title":"Eosinophilic inflammation in asthma","volume":"323","author":"Bousquet","year":"1990","journal-title":"N Engl J Med"},{"key":"2026030321495917200_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000236980","article-title":"Airways remodelling in asthma: no doubt, no more?","volume":"107","author":"Bousquet","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"2026030321495917200_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri.2017.86","article-title":"Innate lymphoid cells: major players in inflammatory diseases","volume":"17","author":"Ebbo","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"2026030321495917200_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nri3349","article-title":"Innate lymphoid cells: how did we miss them?","volume":"13","author":"Walker","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"2026030321495917200_bib8","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/all.12446","article-title":"Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice","volume":"69","author":"Drake","year":"2014","journal-title":"Allergy"},{"key":"2026030321495917200_bib9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ni.2104","article-title":"Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161","volume":"12","author":"Mj\u00f6sberg","year":"2011","journal-title":"Nat Immunol"},{"key":"2026030321495917200_bib10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1164\/rccm.201212-2227OC","article-title":"IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps","volume":"188","author":"Shaw","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321495917200_bib11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.1102832","article-title":"IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs","volume":"188","author":"Bartemes","year":"2012","journal-title":"J Immunol"},{"key":"2026030321495917200_bib12","first-page":"104","article-title":"Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma","volume-title":"J Allergy Clin Immunol","author":"Shikotra","year":"2012"},{"key":"2026030321495917200_bib13","first-page":"59","article-title":"Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33","volume-title":"J Allergy Clin Immunol","author":"Christianson","year":"2015"},{"key":"2026030321495917200_bib14","first-page":"75","article-title":"Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia","volume-title":"J Allergy Clin Immunol","author":"Smith","year":"2016"},{"key":"2026030321495917200_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4049\/jimmunol.170.1.421","article-title":"Transgenic expression of stromal cell-derived factor-1\/CXC chemokine ligand 12 enhances myeloid progenitor cell survival\/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo","volume":"170","author":"Broxmeyer","year":"2003","journal-title":"J Immunol"},{"key":"2026030321495917200_bib16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat Immunol"},{"key":"2026030321495917200_bib17","first-page":"191","article-title":"Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity","volume-title":"J Allergy Clin Immunol","author":"Barlow","year":"2012"},{"key":"2026030321495917200_bib18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/eji.201142018","article-title":"Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma","volume":"42","author":"Klein Wolterink","year":"2012","journal-title":"Eur J Immunol"},{"key":"2026030321495917200_bib19","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1164\/rccm.201612-2427OC","article-title":"Allergen-induced increases in sputum levels of group 2 innate lymphoid cells in subjects with asthma","volume":"196","author":"Chen","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321495917200_bib20","first-page":"61","article-title":"Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients","volume-title":"J Allergy Clin Immunol","author":"Winkler","year":"2019"},{"key":"2026030321495917200_bib21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/mi.2013.92","article-title":"TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers","volume":"7","author":"Yu","year":"2014","journal-title":"Mucosal Immunol"},{"key":"2026030321495917200_bib22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/mi.2013.114","article-title":"The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells","volume":"7","author":"Meylan","year":"2014","journal-title":"Mucosal Immunol"},{"key":"2026030321495917200_bib23","first-page":"4509","article-title":"TNFR2 signaling enhances ILC2 survival, function, and induction of airway hyperreactivity","volume-title":"Cell Rep","author":"Hurrell","year":"2019"},{"key":"2026030321495917200_bib24","first-page":"1939","article-title":"GITR cosignal in ILC2s controls allergic lung inflammation","volume-title":"J Allergy Clin Immunol","author":"Nagashima","year":"2018"},{"key":"2026030321495917200_bib25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41385-019-0215-8","article-title":"Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps","volume":"13","author":"Ogasawara","year":"2020","journal-title":"Mucosal Immunol"},{"key":"2026030321495917200_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1074-7613(02)00283-2","article-title":"TL1A is a TNF-like ligand for DR3 and TR6\/DcR3 and functions as a T cell costimulator","volume":"16","author":"Migone","year":"2002","journal-title":"Immunity"},{"key":"2026030321495917200_bib27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng.175","article-title":"Genome-wide association defines more than 30 distinct susceptibility loci for Crohn\u2019s disease","volume":"40","author":"Barrett","year":"2008","journal-title":"Nat Genet"},{"key":"2026030321495917200_bib28","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/hmg\/ddi379","article-title":"Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn\u2019s disease","volume":"14","author":"Yamazaki","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2026030321495917200_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/08923973.2015.1130721","article-title":"Biologics beyond TNF-\u03b1 inhibitors and the effect of targeting the homologues TL1A-DR3 pathway in chronic inflammatory disorders","volume":"38","author":"Tougaard","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2026030321495917200_bib30","first-page":"257","article-title":"Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin","volume-title":"J Allergy Clin Immunol","author":"Liu","year":"2018"},{"key":"2026030321495917200_bib31","doi-asserted-by":"crossref","first-page":"AB285","DOI":"10.1016\/j.jaci.2017.12.908","article-title":"Type 2 innate lymphoid cells expressing death receptor 3 are increased in airway of mild atopic asthmatic subject following allergen inhalation challenge [abstract]","volume":"141","author":"Machida","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321495917200_bib32","first-page":"264","article-title":"Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to histamine","volume":"135","author":"Cockcroft","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2026030321495917200_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0091-6749(88)90230-8","article-title":"Allergen-induced airway hyperresponsiveness","volume":"81","author":"O\u2019Byrne","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321495917200_bib34","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1164\/ajrccm.154.2.8756799","article-title":"Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements","volume":"154","author":"Pizzichini","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321495917200_bib35","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2017.06.033","article-title":"Sputum autoantibodies in patients with severe eosinophilic asthma","volume":"141","author":"Mukherjee","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321495917200_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/ijpvm.IJPVM_179_16","article-title":"Comparison of interleukin-33 serum levels in asthmatic patients with a control group and relation with the severity of the disease","volume":"8","author":"Momen","year":"2017","journal-title":"Int J Prev Med"},{"key":"2026030321495917200_bib37","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.jaci.2014.12.1918","article-title":"Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma","volume":"135","author":"Smith","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"2026030321495917200_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1165\/rcmb.2016-0262OC","article-title":"Human bronchial epithelial cell-derived factors from severe asthmatic subjects stimulate eosinophil differentiation","volume":"58","author":"Salter","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026030321495917200_bib39","doi-asserted-by":"crossref","first-page":"eaao6923","DOI":"10.1126\/sciimmunol.aao6923","article-title":"ROR\u03b1-expressing T regulatory cells restrain allergic skin inflammation","volume":"3","author":"Malhotra","year":"2018","journal-title":"Sci Immunol"},{"key":"2026030321495917200_bib40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13073-016-0329-5","article-title":"Targeted genomic analysis reveals widespread autoimmune disease association with regulatory variants in the TNF superfamily cytokine signalling network","volume":"8","author":"Richard","year":"2016","journal-title":"Genome Med"},{"key":"2026030321495917200_bib41","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1038\/ncomms3675","article-title":"Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation","volume":"4","author":"Kabata","year":"2013","journal-title":"Nat Commun"},{"key":"2026030321495917200_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/intimm\/dxx030","article-title":"Activation of group 2 innate lymphoid cells exacerbates and confers corticosteroid resistance to mouse nasal type 2 inflammation","volume":"29","author":"Morikawa","year":"2017","journal-title":"Int Immunol"},{"key":"2026030321495917200_bib43","first-page":"1722","article-title":"Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells","volume-title":"J Allergy Clin Immunol","author":"Luo","year":"2019"},{"key":"2026030321495917200_bib44","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/all.13438","article-title":"ILC2 frequency and activity are inhibited by glucocorticoid treatment via STAT pathway in patients with asthma","volume":"73","author":"Yu","year":"2018","journal-title":"Allergy"},{"key":"2026030321495917200_bib45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clim.2014.09.007","article-title":"Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness","volume":"155","author":"Walford","year":"2014","journal-title":"Clin Immunol"},{"key":"2026030321495917200_bib46","first-page":"1147","article-title":"Il-10, tgf-beta, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells","volume-title":"J Allergy Clin Immunol","author":"Ogasawara","year":"2018"},{"key":"2026030321495917200_bib47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/rccm.201804-0809OC","article-title":"Sputum antineutrophil cytoplasmic antibodies in serum antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis","volume":"199","author":"Mukherjee","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321495917200_bib48","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.4049\/jimmunol.178.11.7325","article-title":"Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis","volume":"178","author":"Cassatella","year":"2007","journal-title":"J Immunol"},{"key":"2026030321495917200_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/03009742.2012.727026","article-title":"Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis","volume":"42","author":"Sun","year":"2013","journal-title":"Scand J Rheumatol"},{"key":"2026030321495917200_bib50","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clim.2008.07.014","article-title":"Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis","volume":"129","author":"Bamias","year":"2008","journal-title":"Clin Immunol"},{"key":"2026030321495917200_bib51","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.4049\/jimmunol.0802645","article-title":"Role of TL1A in the pathogenesis of rheumatoid arthritis","volume":"183","author":"Zhang","year":"2009","journal-title":"J Immunol"},{"key":"2026030321495917200_bib52","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fimmu.2019.00583","article-title":"Tl1a (tnfsf15) and dr3 (tnfrsf25): a co-stimulatory system of cytokines with diverse functions in gut mucosal immunity","volume":"10","author":"Valatas","year":"2019","journal-title":"Front Immunol"},{"key":"2026030321495917200_bib53","first-page":"16","article-title":"Tl1a\/dr3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis","volume":"13","author":"Facco","year":"2015","journal-title":"CMA"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/8\/1105\/67175933\/ajrccm_202_8_1105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/8\/1105\/67175933\/ajrccm_202_8_1105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:50:12Z","timestamp":1772592612000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/202\/8\/1105\/8495228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":53,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,10,1]]},"published-print":{"date-parts":[[2020,10,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201909-1722oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"2019-09-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}